Revelation Biosciences (REVB) Earnings Date & Reports

Revelation Biosciences Inc is a clinical-stage life science company focused on rebalancing inflammation to optimize health using its proprietary formulation, Gemini... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

REVB is expected to report earnings to fall 49.70% to -82 cents per share on August 07

Revelation Biosciences REVB Stock Earnings Reports

Q2'26

Est.

$-0.83

Q4'25

Beat

by $8.25

Q3'25

Beat

by $7.83

Q2'25

Beat

by $1.99

Q1'25

Beat

by $6.89

The last earnings report on February 26 showed earnings per share of -164 cents, beating the estimate of -989 cents. With 30.98K shares outstanding, the current market capitalization sits at 3.79M.

View a ticker or compare two or three

Compare

REVB

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for REVB